In metabolic conditions such as obesity and diabetes, which are associated with
deregulated signaling of the insulin/insulin-like growth factor system (IIGFs), inflammation …

The receptor for advanced glycation end‐products (RAGE or AGER) is a transmembrane,
immunoglobulin‐like receptor that, due to its multiple isoform structures, binds to a diverse …

The receptor for advanced glycation end products (RAGE) is a member of the
immunoglobulin family that is overexpressed in several cancers. RAGE is highly expressed …

Inflammation primarily influences the initiation, progression, and deterioration of many
human diseases, and immune cells are the principal forces that modulate the balance of …

Endometrial cancer is one of the most common cancers in women worldwide and its
incidence is increasing. Epidemiological evidence shows a strong association between …

Exosomes are extracellular vesicles with a diameter of 30–150 nm that function in mediating
intercellular communication and intercellular material exchange. The liposomal membrane …

From attributing mutations to cancers with the advent of cutting-edge genetic technology in
recent decades, to re-searching the age-old theory of intrinsic metabolic shift of cancers …

Microalgae have been identified as one of the most promising sources of novel bioactive
compounds for biomedical applications, the food industry, and cosmetics. In the last decade …

Endometrial cancer (EC) is a common malignant tumor that is closely associated with
metabolic disorders such as diabetes and obesity. Advanced glycation end products (AGEs) …

Background. Receptor for advanced glycation end products (RAGE) is implicated in tumor
biology. Released high mobility group box protein 1 (HMGB1) ligand binding to RAGE …